Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiming Li

Showing results (571-580 of 592) with videos related to

Pageof 60
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2023
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical TrialTingyu Wang, Xiuhua Sun, Lihua Qiu, et al.
The British Journal of Dermatology|November 29, 2025
Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trialDuoqin Wang, Jiyuan Wu, Qing Guo, et al.
Signal Transduction and Targeted Therapy|June 8, 2026
Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 studyYe Guo, Zhendong Li, Liqiong Xue, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 29, 2026
Biodegradable Acoustic Targeting for Ultrasound-Supported Gene Therapy (BATUS) in GlioblastomaGulsah Erel-Akbaba, Jinyoung Park, Achal Duhoon, et al.
Photodiagnosis and Photodynamic Therapy|March 31, 2023
Hemoporfin-mediated photodynamic therapy for the treatment of port-wine stain: A multicenter, retrospective studyXiaofeng Zhang, Chen Yuan, Xuemin Xiao, et al.
American Journal of Hematology|August 30, 2023
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label studyLijuan Deng, Zhiming Li, Huilai Zhang, et al.
Cell|May 8, 2026
A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancersYiyun Wang, Ailing Zhong, Bo Wang, et al.
Molecular Psychiatry|April 21, 2022
Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depressionZhiming Li, Jianbo Lai, Peifen Zhang, et al.
Chinese Medical Journal|September 8, 2025
Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trialKun Huang, Songmei Geng, Xiaohua Tao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2026
Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world studyWang Liao, Qun Yu, Bin Chen, et al.
Pageof 60

Showing results (571-580 of 592) with videos related to

Sort By:
Pageof 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2023
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical TrialTingyu Wang, Xiuhua Sun, Lihua Qiu, et al.
The British Journal of Dermatology|November 29, 2025
Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trialDuoqin Wang, Jiyuan Wu, Qing Guo, et al.
Signal Transduction and Targeted Therapy|June 8, 2026
Efficacy and safety of toripalimab in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): a phase 1b/2 studyYe Guo, Zhendong Li, Liqiong Xue, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 29, 2026
Biodegradable Acoustic Targeting for Ultrasound-Supported Gene Therapy (BATUS) in GlioblastomaGulsah Erel-Akbaba, Jinyoung Park, Achal Duhoon, et al.
Photodiagnosis and Photodynamic Therapy|March 31, 2023
Hemoporfin-mediated photodynamic therapy for the treatment of port-wine stain: A multicenter, retrospective studyXiaofeng Zhang, Chen Yuan, Xuemin Xiao, et al.
American Journal of Hematology|August 30, 2023
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label studyLijuan Deng, Zhiming Li, Huilai Zhang, et al.
Cell|May 8, 2026
A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancersYiyun Wang, Ailing Zhong, Bo Wang, et al.
Molecular Psychiatry|April 21, 2022
Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depressionZhiming Li, Jianbo Lai, Peifen Zhang, et al.
Chinese Medical Journal|September 8, 2025
Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trialKun Huang, Songmei Geng, Xiaohua Tao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 13, 2026
Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world studyWang Liao, Qun Yu, Bin Chen, et al.
Pageof 60